Our analyses showed physiological expression of MEIS1 in pro-B-cells and aberrant activity in the KMT2A subtype of BCP-ALL patients and cell lines KOPN-8 and SEM (Figure 2 and Figure 3). Here, MEIS1 is linked to acute lymphoblastic leukemia.